EQT to acquire Qiagen for €46.50 per share in cash
- Location
- Venlo · 🇸🇪 Sweden / Netherlands
- Sector
- Healthcare
- Organisations
- EQT (über Crown NL Bidco) ↔ Qiagen
- Transaction
- Acquisition (voluntary public cash offer)
- Volume
- €46.50 per share in cash, about €10.8bn enterprise value
- Status
- announced
On 21 October 2026 Qiagen signed a business combination agreement with EQT's bidder Crown NL Bidco: a voluntary public cash offer of €46.50 per share values the diagnostics group at about €10.8bn (enterprise value). According to the company, closing is planned for mid-2027 and depends on a minimum acceptance level and regulatory clearances, after which the stock market listings are to end. Qiagen also suspends its 2026 outlook (Qiagen, ad hoc notice, 21 Oct 2026; second source: RTTNews, 22 Oct 2026).
Source: finanznachrichten.de ↗ · Archived copy ↗
Further sources: rttnews.com ↗ (Archived copy ↗)
Evidence: 2 independent sources · archived copy saved · How well sourced is Eurotrack?
More from: 🇸🇪 Sweden · 🇳🇱 Netherlands